Propiedad y actividad de insiders de Annovis Bio, Inc. (ANVS): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $1.04 |
| Capitalización | $44M |
| Bolsa | NYSE |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-05-20 | Hoffman Michael B | P-Purchase | 54,933 | $104K |
| 2026-05-20 | Hoffman Michael B | P-Purchase | 18,849 | $34K |
| 2026-05-20 | Hoffman Michael B | P-Purchase | 2,562 | $4K |
| 2026-04-02 | Hoffman Michael B | P-Purchase | 713,800 | $1.5M |
| 2025-12-08 | Hoffman Michael B | P-Purchase | 15,000 | $64K |
| 2025-12-08 | Hoffman Michael B | P-Purchase | 30,000 | $130K |
| 2025-11-24 | Hoffman Michael B | P-Purchase | 28,096 | $117K |
| 2025-11-24 | Hoffman Michael B | P-Purchase | 415 | $2K |
| 2025-11-24 | Hoffman Michael B | P-Purchase | 9,200 | $35K |
| 2025-11-24 | Hoffman Michael B | P-Purchase | 1,489 | $6K |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $347472 | $35312 | $1858 | $8.1M | $45.7M | $28.4M | $5.8M | $10.6M | $19.5M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | $735075 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | -$745.6M | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $357963 | $50992 | $747512 | $8.1M | $46.0M | $36.0M | $10.2M | $13.9M | $21.1M |
| Inmovilizado Material | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $357963 | $50992 | $1.1M | $8.1M | $46.0M | $36.0M | $10.2M | $13.9M | $21.1M |
| Cuentas por Pagar | $71107 | $68425 | $1.2M | $341856 | $688074 | $4.0M | $1.3M | $2.3M | $2.6M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $490220 | $567943 | $2.0M | $578380 | $1.5M | $7.7M | $4.3M | $3.9M | $3.6M |
| Deuda a Largo | 0 | 0 | $499807 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $7.3M | $7.6M | $9.7M | $578380 | $1.5M | $7.7M | $18.0M | $4.6M | $4.2M |
| Reservas | -$7.1M | -$7.8M | -$8.8M | -$14.2M | -$28.7M | -$54.1M | -$110.3M | -$134.8M | -$163.7M |
| Patrimonio Neto | -$7.0M | -$7.6M | -$8.6M | $7.5M | $44.5M | $28.3M | -$7.8M | $9.3M | $16.9M |
| Deuda Total | 0 | 0 | $499807 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deuda Neta | -$347472 | -$35312 | $497949 | -$8.1M | -$45.7M | -$28.4M | -$5.8M | -$10.6M | -$19.5M |
| Capital Circulante | -$132257 | -$516951 | -$1.3M | $7.5M | $44.5M | $28.3M | $5.9M | $10.0M | $17.4M |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 2.95 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -4.44 |
Rentabilidad
| Rentabilidad sobre capital | -685.96% |
| Rentabilidad sobre capital invertido | -400.40% |
| Rentabilidad sobre activos | -224.73% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: ATNM · BCAB · BTAI · CELU · ELUT · EVAX · MAIA
Explorar sector: Healthcare · Biotechnology
Más secciones de ANVS: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones